[ 바이젠셀 ] 긴급속보 임상2상 조건부허가 내년 신청 성공시 매출 1200억! 지금이 기회다 #바이젠셀주가 #바이젠셀주가전망
Published December 5, 2025
Views 53 | Likes 30 | Comments 0
Based on an estimated $0.7–$2 CPM, this video's 53 views translate to an estimated $0 – $0 in lifetime ad revenue.
Revenue estimate
Based on an estimated $0.7–$2CPM (revenue per 1,000 views) — a rough public estimate, not actual creator earnings, which depend on ad rates, audience geography, and monetization settings YouTube doesn't expose publicly.
Total (all-time)$0 – $0